Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Zhihao Lü(Nanjing Tech University), Malcolm V. Brock(Johns Hopkins University), Ken Kang‐Hsin Wang(The University of Texas Southwestern Medical Center), Rosalyn A. Juergens(McMaster University), Yanni Wang(Zhejiang Chinese Medical University), Barry D. Nelkin(Johns Hopkins University), KiBem Kim(Johns Hopkins University), Julie R. Brahmer(Johns Hopkins University), Stephen C. Yang(Johns Hopkins University), Peng Huang(Johns Hopkins University), Yong Tao(Shanghai Ninth People's Hospital), Stephen Broderick(Johns Hopkins University), Hariharan Easwaran(Johns Hopkins University), Wenbing Xie(Johns Hopkins University), Limin Xia(National Clinical Research Center for Digestive Diseases), Michelle Vaz(Johns Hopkins University), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Joanne Riemer(Johns Hopkins University), Franck Housseau(Centre National de la Recherche Scientifique), Cynthia A. Zahnow(Johns Hopkins University), Stephen B. Baylin(Johns Hopkins University), Patrick M. Forde(Sidney Kimmel Comprehensive Cancer Center), Michael J. Topper(Johns Hopkins University), Drew M. Pardoll(Bloomberg (United States)), Yi Cai(Johns Hopkins University), Errol L. Bush(Johns Hopkins University), Jianling Zou(Shanghai Jiao Tong University), Xiangqian Kong(University of Science and Technology of China), John Wrangle(Johns Hopkins University), Alicia Hulbert(Johns Hopkins University), Young J. Kim(Regeneron (United States)), Hao Zhang(Northwestern Polytechnical University), Shuang Li(Sun Yat-sen University), Yujiao Wang(Peking University), Weiqiang Zhang(Johns Hopkins University), Lin Shen(Hangzhou Normal University), Huili Li(Pingdingshan University), Joseph B. Margolick(Johns Hopkins University), Ying Cui(Zero to Three), Xi Jiao(Peking University), Bin Zhang(Dalian University of Technology), Chi-Ping Day(National Institutes of Health), Ray-Whay Chiu Yen(Johns Hopkins University), Yuping Mei(Johns Hopkins Hospital), Richard J. Battafarano(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Stephen M. Cattaneo(Anne Arundel Medical Center), Beverly Lee(Lovelace Respiratory Research Institute)
Cited by 339
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k